Misplaced Pages

Smith-Kingsmore syndrome: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 11:05, 10 January 2025 editCmr08 (talk | contribs)Autopatrolled, Extended confirmed users124,454 edits put infobox before the introduction per WP:LAYOUT← Previous edit Revision as of 17:06, 13 January 2025 edit undoBoyTheKingCanDance (talk | contribs)Extended confirmed users, Page movers, New page reviewers, Pending changes reviewers176,450 edits Added tags to the page using Page Curation (improve categories)Tag: PageTriageNext edit →
Line 1: Line 1:

{{Infobox medical condition {{Infobox medical condition
| name = Smith-Kingsmore Syndrome | name = Smith-Kingsmore Syndrome
Line 66: Line 67:


] ]
{{improve categories|date=January 2025}}

Revision as of 17:06, 13 January 2025

Medical condition
Smith-Kingsmore Syndrome
Other namesSKS
Smith-Kingsmore Syndrome is inherited in Autosomal Dominant fashion.
CausesGain-of-function mutation in MTOR

Smith-Kingsmore syndrome is a rare genetic disorder that is caused by gain-of-function mutation in a gene MTOR. The facial features of this syndrome are triangular face with a pointed chin, frontal bossing, hypertelorism, eyes with downslanting palpebral fissures, a flat nasal bridge, a long philtrum.

Presentation

The signs of this disease are:

Very frequent:

  • Intellectual Disability
  • Macrocephaly

Frequent:

  • Abnormal facial shape
  • Abnormality of speech
  • Curly Hair
  • Seizure
  • Frontal bossing
  • Ventriculomegaly

Occasional:

  • Autistic Behaviour
  • Cafe-au-lait spot
  • Gait Disturbance
  • Hypertelorism
  • Hypotonia
  • Open mouth
  • Long philtrum
  • Polymicrogyria
  • Prominient forehead

Very rare:

  • Downslanted palpebral fissures
  • Depressed nasal bridge
  • Decreased circulating IgA level
A photo showing 4 patients showing characteristic facial signs of Smith-Kingsmore syndrome.

Cause

The cause of SKS is gain-of-function mutation in a gene MTOR.

This disease is inherited in Autosomal Dominant fashion, but most of the times it’s de-novo mutation.

Diagnosis

SKS is a rare condition so many physicians aren’t familiar with. A diagnosis of SKS is suspected based upon the identification of symptoms, a patient and family history and a thorough clinical evaluation.

SKS can be confirmed with the detection of a germline or mosaic mutation in the MTOR gene.

Frequency

Frequency of this disease is unknown, but all ethnic groups are equally affected

Treatment

There is no cure for SKS, but management of some symptoms can be achieved

History

SKS was first described by Dr Smith, L.D et al. in 2013.

References

This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles. (January 2025)
  1. "Smith-Kingsmore syndrome: MedlinePlus Genetics". medlineplus.gov. Retrieved 2025-01-06.
  2. "Orphanet: Clinical signs and symptoms". www.orpha.net. Retrieved 2025-01-06.
  3. "Clinical and functional studies of MTOR variants in Smith-Kingsmore syndrome reveal deficits of circadian rhythm and sleep-wake behavior". HGG Advances.
  4. Allen, Andrew S.; Berkovic, Samuel F.; Cossette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Howell, Katherine B.; Johnson, Michael R.; Kuzniecky, Ruben (September 2013). "De novo mutations in epileptic encephalopathies". Nature. 501 (7466): 217–221. doi:10.1038/nature12439. ISSN 1476-4687. PMC 3773011. PMID 23934111.
  5. Mroske, Cameron; Rasmussen, Kristen; Shinde, Deepali N.; Huether, Robert; Powis, Zoe; Lu, Hsiao-Mei; Baxter, Ruth M.; McPherson, Elizabeth; Tang, Sha (2015-11-05). "Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities". BMC Medical Genetics. 16 (1): 102. doi:10.1186/s12881-015-0240-8. ISSN 1471-2350. PMC 4635597. PMID 26542245.
  6. ^ "Smith-Kingsmore Syndrome - Symptoms, Causes, Treatment | NORD". rarediseases.org. Retrieved 2025-01-06.
  7. "Smith-Kingsmore Syndrome - Symptoms, Causes, Treatment | NORD". rarediseases.org. Retrieved 2025-01-06.
  8. "Managing/Treating SKS – SKS". Retrieved 2025-01-06.
  9. Smith, Laurie D.; Saunders, Carol J.; Dinwiddie, Darrell L.; Atherton, Andrea M.; Miller, Neil A.; Soden, Sarah E.; Farrow, Emily G.; Abdelmoity, Ahmed T. G.; Kingsmore, Stephen F. (2013-09-04). "Exome Sequencing Reveals De Novo Germline Mutation of the Mammalian Target of Rapamycin (MTOR) in a Patient with Megalencephaly and Intractable Seizures". Journal of Genomes and Exomes. 2013 (2): 63–72. doi:10.4137/JGE.S12583. ISSN 2253-5004.
Category:
Smith-Kingsmore syndrome: Difference between revisions Add topic